ASH Letter to FDA re Draft on Collection of Race and Ethnicity Data in Clinical Trials and Studies

American Society of Hematology. (2024).
ASH Letter to FDA re Draft on Collection of Race and Ethnicity Data in Clinical Trials and Studies.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-on-collection-of-race-and-ethnicity-data-in-clinical-trials-and-studies.

American Society of Hematology.
"ASH Letter to FDA re Draft on Collection of Race and Ethnicity Data in Clinical Trials and Studies." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-on-collection-of-race-and-ethnicity-data-in-clinical-trials-and-studies
(label-accessed December 15, 2024).

"American Society of Hematology."
ASH Letter to FDA re Draft on Collection of Race and Ethnicity Data in Clinical Trials and Studies, 15 Dec. 2024 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-to-fda-re-draft-on-collection-of-race-and-ethnicity-data-in-clinical-trials-and-studies.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero